Showing results (81-90 of 259) with videos related to

Sort By:
Pageof 26
Cellular and Molecular Life Sciences : CMLS|April 2, 2010
Positive regulation of apoptosis signal-regulating kinase 1 by dual-specificity phosphatase 13AJae Eun Park, Byoung Chul Park, Hyun-A Kim, et al.
Oncology Research|February 15, 2012
The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell deathLina Ren, Hee-Young Yang, Hoon-In Choi, et al.
Plos One|May 7, 2021
Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registryKwai Han Yoo, Hyeoung-Joon Kim, Yoo Hong Min, et al.
The Korean Journal of Laboratory Medicine|September 4, 2009
[Detection of putative T cell clones using T cell receptor beta chain gene clonality assay in Korean patients with aplastic anemia]Hyun-Jung Choi, Myung-Geun Shin, Hye-Ran Kim, et al.
DNA and Cell Biology|June 3, 2011
H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in KoreansXue Mei Jin, Hee Nam Kim, Min-Ho Shin, et al.
Journal of Korean Medical Science|August 30, 2008
Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancerJunyl Hwang, Sang-Hee Cho, Hyun Jeong Shim, et al.
Colloids and Surfaces. B, Biointerfaces|June 2, 2014
Selective transfection with osmotically active sorbitol modified PEI nanoparticles for enhanced anti-cancer gene therapyKim Cuc Thi Nguyen, Muthunarayanan Muthiah, Mohammad Ariful Islam, et al.
The Korean Journal of Internal Medicine|February 14, 2019
Cellular immunotherapy in multiple myelomaManh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung-Hoon Jung, et al.
Medicine|January 12, 2021
Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry dataIk-Chan Song, Deog-Yeon Jo, Hyeoung-Joon Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2010
The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemiaDong Hwan Dennis Kim, Jee Hyun Kong, Ji Young Byeun, et al.
Pageof 26